Deng Lab

In Summer 2026, NeuroCoolX participated in the IU LAB Pre-Accelerator powered by gBETA gener8tor, a highly selective program designed to help researchers and entrepreneurs translate innovative technologies into real-world solutions. Co-founded by Dr. Lingxiao Deng and Dr. Gao, both faculty members at Indiana University School of Medicine, NeuroCoolX entered the program with a strong scientific foundation and a vision to improve outcomes for patients with acute neurotrauma. For academic...

We are pleased to share that our recent publication in The Journal of Neuroscience has been selected as Featured Research by the Journal of Neuroscience. This distinction highlights studies that are considered particularly important, novel, and broadly impactful in the field. As part of this recognition, our work has been featured on the journal’s platform and promoted across multiple scientific communication channels. Our study demonstrates a clinically feasible strategy using the...

We are excited to share our latest publication in The Journal of Neuroscience titled “Repurposing Dexmedetomidine: Early Pharmacological Hypothermia Enhances Neuroprotection and Improves Locomotor and Bladder Functional Recovery after Spinal Cord Injury.” DOI: 10.1523/JNEUROSCI.0007-26.2026 In this study, we demonstrate that dexmedetomidine (Dex), an FDA-approved drug, can induce rapid pharmacological hypothermia after spinal cord injury, providing a clinically feasible and equipment-free...